150 related articles for article (PubMed ID: 22557877)
1. Toxoplasmic pachymeningitis with visual field impairment in a single-eyed patient and a literature review.
Bonnin N; Chiambaretta F; Ulla M; Taithe F; Chabert E; Claise B; Bacin F
Oman J Ophthalmol; 2012 Jan; 5(1):46-50. PubMed ID: 22557877
[TBL] [Abstract][Full Text] [Related]
2. A prospective randomized trial of azithromycin versus trimethoprim/sulfamethoxazole in treatment of toxoplasmic retinochoroiditis.
Lashay A; Mirshahi A; Parandin N; Riazi Esfahani H; Mazloumi M; Reza Lashay M; Johari MK; Ashrafi E
J Curr Ophthalmol; 2017 Jun; 29(2):120-125. PubMed ID: 28626822
[TBL] [Abstract][Full Text] [Related]
3. Low-dose trimethoprim-sulfamethoxazole prophylaxis for toxoplasmic encephalitis in patients with AIDS.
Carr A; Tindall B; Brew BJ; Marriott DJ; Harkness JL; Penny R; Cooper DA
Ann Intern Med; 1992 Jul; 117(2):106-11. PubMed ID: 1351371
[TBL] [Abstract][Full Text] [Related]
4. [Epidemiologic characteristics of cerebral toxoplasmosis in 399 HIV-infected patients followed between 1983 and 1994].
Bossi P; Caumes E; Astagneau P; Li TS; Paris L; Mengual X; Katlama C; Bricaire F
Rev Med Interne; 1998 May; 19(5):313-7. PubMed ID: 9775164
[TBL] [Abstract][Full Text] [Related]
5. Desensitization to trimethoprim-sulfamethoxazole in a toxoplasmic encephalitis patient who was intolerant to conventional treatments.
Miyata N; Yoshimura Y; Hikosaka K; Norose K; Tachikawa N
J Infect Chemother; 2020 Mar; 26(3):289-293. PubMed ID: 31711832
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal Injection of Sulfamethoxazole and Trimethoprim Associated with Dexamethasone as an Alternative Therapy for Ocular Toxoplasmosis.
Souza CE; Nascimento H; Lima A; Muccioli C; Belfort R
Ocul Immunol Inflamm; 2018; 26(7):1041-1044. PubMed ID: 28448726
[TBL] [Abstract][Full Text] [Related]
7. Diffuse toxoplasmic retinochoroiditis as the initial manifestation of acquired immunodeficiency syndrome.
Lee YF; Chen SJ; Chung YM; Liu JH; Wong WW
J Formos Med Assoc; 2000 Mar; 99(3):219-23. PubMed ID: 10820954
[TBL] [Abstract][Full Text] [Related]
8. Toxoplasmic encephalitis after allogeneic hematopoietic stem cell transplantation.
Cetinkaya FI; Mumcu N; Unuvar GK; Kilic AU; Kaynar L
North Clin Istanb; 2022; 9(3):282-285. PubMed ID: 36199860
[TBL] [Abstract][Full Text] [Related]
9. Impact of visual impairment on measures of cognitive function for children with congenital toxoplasmosis: implications for compensatory intervention strategies.
Roizen N; Kasza K; Karrison T; Mets M; Noble AG; Boyer K; Swisher C; Meier P; Remington J; Jalbrzikowski J; McLeod R; Kipp M; Rabiah P; Chamot D; Estes R; Cezar S; Mack D; Pfiffner L; Stein M; Danis B; Patel D; Hopkins J; Holfels E; Stein L; Withers S; Cameron A; Perkins J; Heydemann P
Pediatrics; 2006 Aug; 118(2):e379-90. PubMed ID: 16864640
[TBL] [Abstract][Full Text] [Related]
10. Morphological characteristics of ocular toxoplasmosis and its regression pattern on swept-source optical coherence tomography angiography: a case report.
Park JH; Lee SY; Lee EK
BMC Ophthalmol; 2019 Sep; 19(1):199. PubMed ID: 31488090
[TBL] [Abstract][Full Text] [Related]
11. Foveal reorganization after treatment of acute foveal toxoplasmic retinochoroiditis.
Abrishami M; Hosseini SM; Momtahen S; Zamani G
J Ophthalmic Inflamm Infect; 2021 Jun; 11(1):18. PubMed ID: 34151385
[TBL] [Abstract][Full Text] [Related]
12. Idiopathic hypertrophic cranial pachymeningitis: Three biopsy-proven cases including one case with abdominal pseudotumor and review of the literature.
Hassan KM; Deb P; Bhatoe HS
Ann Indian Acad Neurol; 2011 Jul; 14(3):189-93. PubMed ID: 22028532
[TBL] [Abstract][Full Text] [Related]
13. Prospective randomized trial of trimethoprim/sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis.
Soheilian M; Sadoughi MM; Ghajarnia M; Dehghan MH; Yazdani S; Behboudi H; Anisian A; Peyman GA
Ophthalmology; 2005 Nov; 112(11):1876-82. PubMed ID: 16171866
[TBL] [Abstract][Full Text] [Related]
14. Detection of toxoplasmic lesions in mouse brain by USPIO-enhanced magnetic resonance imaging.
Wei L; Zhou G; Li Z; He L; Gao M; Tan J; Lei H
Magn Reson Imaging; 2007 Dec; 25(10):1442-8. PubMed ID: 17614231
[TBL] [Abstract][Full Text] [Related]
15. Tuberculous Hypertrophic Pachymeningitis.
Cordeiro NL; Gupta SS; Kanwar A; Bendor-Grynbaum C; Sharma JB
Cureus; 2021 Aug; 13(8):e17570. PubMed ID: 34513529
[TBL] [Abstract][Full Text] [Related]
16. Clinical presentation, treatment and outcome of IgG4-related pachymeningitis: From a national case registry and literature review.
Melenotte C; Seguier J; Ebbo M; Kaphan E; Bernit E; Saillier L; Audoin B; Feyeux D; Daniel L; Roche PH; Graillon T; Dufour H; Boutière C; Girard N; Closs-Prophette F; Guillaud C; Tieulié N; Regent A; Harlé JR; Hamidou M; Mekinian A; Grados A; Schleinitz N
Semin Arthritis Rheum; 2019 Dec; 49(3):430-437. PubMed ID: 31155444
[TBL] [Abstract][Full Text] [Related]
17. Congenital central toxoplasmic chorioretinitis - case study.
Maršolková K; Timkovič J; Lesková V; Němčanský J; Wiedermannová H
Cesk Slov Oftalmol; 2018; 74(3):114-118. PubMed ID: 30650975
[TBL] [Abstract][Full Text] [Related]
18. A spectrum in the pathology of toxoplasmosis in patients with acquired immunodeficiency syndrome.
Bertoli F; Espino M; Arosemena JR; Fishback JL; Frenkel JK
Arch Pathol Lab Med; 1995 Mar; 119(3):214-24. PubMed ID: 7887774
[TBL] [Abstract][Full Text] [Related]
19. Idiopathic hypertrophic cranial pachymeningitis.
Sylaja PN; Cherian PJ; Das CK; Radhakrishnan VV; Radhakrishnan K
Neurol India; 2002 Mar; 50(1):53-9. PubMed ID: 11960152
[TBL] [Abstract][Full Text] [Related]
20. IgG4-related hypertrophic pachymeningitis: clinical features, diagnostic criteria, and treatment.
Lu LX; Della-Torre E; Stone JH; Clark SW
JAMA Neurol; 2014 Jun; 71(6):785-93. PubMed ID: 24733677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
